Market Overview:The global spinal muscular atrophy market is estimated to be valued at US$1,600.6 million in 2023 and is projected to grow at a CAGR of 13.3% over the forecast period of 2023-2030. Spinal muscular atrophy is a genetic disorder characterized by the loss of motor neurons, resulting in muscle weakness and atrophy. The market for spinal muscular atrophy products is witnessing...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian